Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 16.3 to 14.5.
Financials
Financial year 2025
XEDEV from Zele, company number BE0845352525, closed financial year 2025 with a result of € 210,653 after tax. For that financial year XEDEV recorded a gross margin of € 1.8 million and equity of € 921,634. Compared with financial year 2024, the result moved from € -334,162 to € 210,653. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 4, 2026.
€ 921,634
▲ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 210,653
▲ still € 334,162 loss in 2024
Profit after tax over the fiscal year.
€ 395,614
▲ 171% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 903,084.
People and assets in 2025
14.5
▼ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.1 million
▼ 4% vs 2024
€ 74,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 8,051
▼ 76% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.4 million
▲ 19% vs 2024
€ 122,917 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 132,642
▲ 79% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 121,306
▲ 3% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,668,832 | € 2,049,201 | € 1,339,713 | € 1,811,756 | ▲ 35% |
| Profit after taxes | € 205,997 | € 241,135 | € -334,162 | € 210,653 | ▲ € 544,814 |
| Equity | € 1,105,531 | € 1,094,993 | € 760,831 | € 921,634 | ▲ 21% |
| Total debts | € 2,631,838 | € 2,309,125 | € 1,465,535 | € 1,797,583 | ▲ 23% |
| Cash | € 722,167 | € 513,162 | € 145,867 | € 395,614 | ▲ 171% |
| Retained profit | € 1,086,981 | € 1,076,443 | € 742,281 | € 903,084 | ▲ 22% |
| Dividend | € 300,000 | € 240,000 | € 0 | € 0 | |
| Bank debt | € 2,034,628 | € 1,717,514 | € 1,198,546 | € 1,427,610 | ▲ 19% |
| Balance sheet total | € 3,737,370 | € 3,404,118 | € 2,226,366 | € 2,719,217 | ▲ 22% |
| Employees (FTE) | 13.8 | 16.3 | 15.2 | 14.5 | ▼ 0.7 |
Key figures of XEDEV, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to XEDEV?
What happened at XEDEV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 210,653. Source: NBB ↗
- VDGTec BV became a director. NBB
- ProVisie BV became a director. NBB
- New establishment in Zele. KBO
- Start of the company according to the CBE. KBO
In short
From € 205,997 profit in 2022 to € 210,653 profit in 2025.
Paid € 85,363 in corporate taxes since 2022.
Best year ever: 2023, with € 241,135 profit.
On average € 124,900 of value added per employee in 2025.
A new publication or filing at XEDEV? We notify you, reason included.
Follow XEDEVDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind XEDEV are VDGTec BV and ProVisie BV. The same people are also behind PROCEPT. ProVisie BV is also behind RE-VISIT.
Directors
According to the 2025 annual accounts
since 2025
Establishments
Establishment units
Physical locations of this company
Poldergotestraat 4
9240 Zele
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Barracuda
Hosting
COMBELL-AS, BE
Domain
Domain
xedev.com
Registered
2008-04-28
Registrar
Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Expires
2026-04-28
Website info
Features
Security
Network
Details
- Company number
- 0845.352.525
- VAT number
- BE 0845.352.525
- Registered office
- Poldergotestraat 4, 9240 Zele
- Names & denominations
- XEDEV
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 April 2012
- Peppol
- Active · Active since 7 Jan 2026
- Contact
- xedev.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige dienstverlenende activiteiten op het gebied van informatie
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van farmaceutische grondstoffen
Overige gespecialiseerde wetenschappelijke en technische activiteiten